Company profile

Hi-D Imaging

Cardiology & Cardiovascular Health

Company profile

About Hi-D Imaging

Hi-D Imaging AG is a Swiss medical technology company specializing in AI-based cardiovascular imaging solutions and digital twin services for pre-operational planning. The company addresses the time-consuming manual work required before cardiac operations, including medical scan segmentation, multi-planar reconstruction, and anatomical measurements that traditionally suffer from up to 20% inter-observer and intra-observer variability. Their flagship product, 4TAVR, is an FDA 510(k) cleared software that provides automated, one-click solutions for structural heart intervention planning, particularly for transcatheter aortic valve replacement (TAVR) procedures. The software delivers all relevant procedure planning measurements and 3D volumes with unprecedented accuracy and speed. Beyond their imaging suite, Hi-D Imaging operates a Digital Twin Lab that creates patient-specific computational models to simulate blood flow under specified conditions. These digital twins help medical device manufacturers optimize product development timelines and costs, reducing the traditional 10+ year development cycle and expensive animal studies. The company's solutions are designed for seamless integration with no training requirements, featuring user-friendly interfaces that healthcare professionals can use within minutes. Hi-D Imaging serves cardiologists, medical device manufacturers, and researchers globally, with validated methods published in high-impact scientific journals. Their technology streamlines clinical workflows while maintaining the highest security standards and providing regular automated updates.

Company description Hi-D Imaging official website

Primary marketCardiology & Cardiovascular Health
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Hi-D Imaging?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • aortic regurgitation
  • aortic stenosis
  • cardiovascular disease
  • structural heart disease

Who it serves

  • Cardiologists
  • Health Systems
  • Medical Device Manufacturers
  • Researchers

Deployment & integration

Cloud Saas · Other deployment with recorded integration context.

Geographic context

MarketsGermany · Spain · Switzerland · United States
Company sourceOfficial website

Company milestones

Platform expansion

FDA 510(k) clearance for 4TAVR software (2024). Innosuisse Scale-Up Coaching program acceptance (2024). Innovation cheque project for next generation personalized artery models in silicone (2024).

Partnerships

Recorded partners

  • ELEM Biotech SL (Spain)
  • Swiss m4m Center
  • Texas Health Harris Methodist Hospital
  • Texas Health Resources
  • University of Giessen Department of Cardiology & Angiology

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Vascular Solutions

AI-based software for cardiovascular pre-operational planning

Software · Cloud SaaSCompany source

4TAVR

AI-powered one-click solution for transcatheter aortic valve replacement planning

Software · Cloud SaaSCompany source

Digital Twin Lab

Patient-specific digital twins for cardiovascular blood flow analysis

Service · OtherCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

Measurement accuracy

Reduces up to 20% inter-observer and intra-observer variability in anatomical measurements

Workflow efficiency

One-click solution for all relevant procedure planning measurements

Time savings

Automates time-consuming manual segmentation and measurement tasks

Device development optimization

Reduces traditional 10+ year medical device development timeline

Texas Health Resources / Texas Health Harris Methodist Hospital

Clinical partnership for structural heart interventions using AI technology for better patient care

Clinical partner in development of cutting-edge technology for structural heart team

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

06 · Company updates

Updates from Hi-D Imaging

Recent articles published on Hi-D Imaging's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Cardiology & Cardiovascular Health

Companies applying AI to cardiovascular disease detection, ECG/EKG analysis, heart failure management, cardiac imaging, arrhythmia detection, or cardiovascular risk assessment. Includes AI-powered cardiac diagnostics, non-invasive hemodynamic monitoring, and tools for early detection and personalized management of heart conditions.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon